DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Dormandy JA, Charbonnel B, Eckland DJ. et al.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial.
Lancet 2005;
366: 1279-1289
We do not assume any responsibility for the contents of the web pages of other providers.